Sentence examples for vitro when the from inspiring English sources

Using this substrate we assayed the effects on rIN catalysis of different classes of compounds which inhibit the HIV-1 rIN in vitro when the reaction substrate is the standard 21mer U5 dsDNA, and that are either active or inactive on the HIV-1 replication.

The expression of the epiblast markers, Cerl, Fgf5, Gata6 and Left-b, increased significantly with the use of the EB method, whereas the expression of only Left-b increased clearly in the attachment culture technique (Fig. 3C), suggesting that an intermediate stage, perhaps an epiblast stage, existed during the process of PGC specification in vitro when the EB method was implemented.

Virus uptake was only increased in vitro when the cells were treated with benzo-α-pyrene, one of the most abundant carcinogens in tobacco smoke.

If this would be the case, the other two kinases should successfully phosphorylate GroES in vitro when the third kinase is knocked out.

In contrast to p618, which readily forms stable oligomers, p529 is only able to oligomerize in vitro when the Walker B motif glutamate is mutated (E177Q), suggesting that dissociation of the complex occurs after ATP hydrolysis.

Together these data indicate that SP1 and SP3 bind more avidly to the T allele of rs143383 in vitro when the +37 CpG site is unmethylated than when this site is methylated.

On the contrary, in postnatal cultures, EL axons decreased with a faster rate and disappeared completely after two weeks in vitro, when all the axons belonged to the AR class (Figure 4B).

These results are consistent with results found in vitro when analyzing the MCM complex formation of the PS1-hp mutants of SsoMCM (McGeoch et al. 2005).

Smaller aerosol particles resulted in greater drug delivery in vitro when using the modified Aeroneb Pro during CMV.

While cis-4-OH-TAM is thought to be primarily an estrogen agonist, this isomer exhibits significant antiestrogenic activity in vitro when in the presence of estradiol [ 22- 24].

We observed a significant reduction in tumour cell proliferation and cell invasiveness, in vitro, when decreasing the STMN1 protein levels by using siRNA-targeting STMN1.